Get the Stockscreener App
3.99
2.31%
0.09
After Hours:
4.07
0.08
+2.01%
Orasure Technologies Inc Stock (OSUR) Latest News
OraSure Technologies (NASDAQ:OSUR) Cut to Hold at StockNews.com - MarketBeat
OraSure (OSUR) Upgraded to Strong Buy: What Does It Mean for the Stock? - MSN
New Strong Buy Stocks for January 27th - Yahoo Finance
Should Value Investors Buy OraSure Technologies (OSUR) Stock? - Yahoo Finance
JPMorgan Chase & Co. Grows Position in OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World
OraSure Technologies (NASDAQ:OSUR) Upgraded at StockNews.com - MarketBeat
Global At-Home Testing Market to Reach USD 11,877.8 Million by 2035 with a CAGR of 4.8%, Driven by Rising Consumer Demand for Self-Diagnostic Tools | Future Market Insights, Inc. - GlobeNewswire Inc.
New Strong Buy Stocks for January 16th - Yahoo Finance
Barclays PLC Buys 126,503 Shares of OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World
OraSure Technologies, Inc. (NASDAQ:OSUR) Shares Bought by Barclays PLC - MarketBeat
Bethlehem manufacturer puts original headquarters up for sale - MSN
Retractable Technologies (NYSE:RVP) and OraSure Technologies (NASDAQ:OSUR) Critical Contrast - Defense World
Over-the-Counter HIV Test Approved for Adolescents - Pulmonology Advisor
NOWDiagnostics Faces Off With Biotech Rival In Trade Secrets Lawsuit - Arkansas Business
NOWDiagnostics Responds with Countersuit Against Frivolous OraSure Claims - BioSpace
OraSure leaving original manufacturing site in Bethlehem - 69News WFMZ-TV
OraSure Technologies (NASDAQ:OSUR) Downgraded by StockNews.com to "Hold" - MarketBeat
OraSure Technologies’ Acquisition of Sherlock Biosciences - Global Legal Chronicle
OraSure to Present at the J.P Morgan Healthcare Conference - The Manila Times
OraSure Technologies, Inc.'s OraQuick HIV Self-Test Receives Approval for Use in Adolescents - Marketscreener.com
NEUBERGER BERMAN GROUP LLC Adjusts Holdings in OraSure Technologies Inc - GuruFocus.com
OraSure Technologies to Present at J.P. Morgan Healthcare Conference 2025 - StockTitan
Are Investors Undervaluing OraSure Technologies (OSUR) Right Now? - Yahoo Finance
FDA Expands OraSure's HIV Self-Test Access to Teens Amid Rising Youth Diagnoses - StockTitan
CORRECTIONOraQuick® HIV Self-Test Now Approved for Use in Adolescents - GlobeNewswire
OraQuick® HIV Self-Test Now Approved for Use in Adolescents - The Manila Times
OraSure Expands OraQuick HIV Self-Test Access to Teens 14+ Amid Rising Youth Cases - StockTitan
OSUR Stock Surges Over 5% Amid Market Activity - GuruFocus.com
Geode Capital Management LLC Purchases 32,929 Shares of OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World
OraSure in 2025: Changes, challenges and silver linings - 69News WFMZ-TV
OraSure Technologies (NASDAQ:OSUR) Upgraded by StockNews.com to Buy Rating - Defense World
Barclays PLC Raises Holdings in OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World
OraSure Technologies, Inc. (NASDAQ:OSUR) Shares Bought by Jane Street Group LLC - Defense World
OraSure Technologies, Inc. (NASDAQ:OSUR) Shares Bought by Franklin Resources Inc. - Defense World
OraSure Technologies Completes Acquisition of Sherlock Biosciences, Inc. - Defense World
State Street Corp Sells 257,093 Shares of OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World
State Street Corp Has $7.48 Million Stock Holdings in OraSure Technologies, Inc. (NASDAQ:OSUR) - MarketBeat
OraSure stock hits 52-week low at $3.58 amid market challenges - Investing.com Canada
OraSure stock hits 52-week low at $3.58 amid market challenges By Investing.com - Investing.com South Africa
OSUR Stock Rises Following the Acquisition of Sherlock Biosciences - MSN
FDA Approves Premarket Approval Application for OraQuick HIV Self-Test, Expanding Access to Adolescents - Pharmacy Times
OraSure Tech stock hits 52-week low at $3.7 amid challenges - Investing.com
OraSure acquires maker of over-the-counter STI tests - 69News WFMZ-TV
OraSure Tech stock hits 52-week low at $3.7 amid challenges By Investing.com - Investing.com South Africa
3.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):